Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...

書誌詳細
主要な著者:	Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M
フォーマット:	Journal article
言語:	English
出版事項:	Springer Nature 2020

類似資料

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
著者:: Yasunori Watanabe, 等
出版事項: (2020-05-01)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
著者:: Watanabe, Y, 等
出版事項: (2018)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
著者:: Crispin, M, 等
出版事項: (2013)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
著者:: Crispin, M, 等
出版事項: (2013)

The impact of sequence diversity on the glycan shield of HIV-1 immunogens
著者:: Seabright, GE
出版事項: (2019)

Beyond Shielding: The Roles of Glycans in the SARS-CoV‑2 Spike Protein
著者:: Lorenzo Casalino, 等
出版事項: (2020-09-01)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
著者:: Pritchard, L, 等
出版事項: (2015)

Architecture of the HIV-1 glycan shield
著者:: Pritchard, L
出版事項: (2014)

Mapping the glycan shields of enveloped viruses
著者:: Watanabe, Y
出版事項: (2020)

Integrity of glycosylation processing of a glycan-depleted trimeric HIV-1 immunogen targeting key B-cell lineages
著者:: Behrens, AJ, 等
出版事項: (2018)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
著者:: Joel D. Allen, 等
出版事項: (2023-04-01)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
著者:: Bonomelli, C, 等
出版事項: (2011)

Glycosylator: a Python framework for the rapid modeling of glycans
著者:: Thomas Lemmin, 等
出版事項: (2019-10-01)

N- and O-glycan analysis for the detection of glycosylation disorders
著者:: Amr Sobhi Gouda, 等
出版事項: (2021-01-01)

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
著者:: Le, N, 等
出版事項: (2016)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
著者:: Camille Bonomelli, 等
出版事項: (2011-01-01)

Fine structure of the HIV-1 glycan shield
著者:: Behrens, A
出版事項: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
著者:: Weiwei Peng, 等
出版事項: (2022-08-01)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
著者:: Mingjun Yang, 等
出版事項: (2017-06-01)

Glycan Nanostructures of Human Coronaviruses
著者:: Guo W, 等
出版事項: (2021-07-01)

Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection.
著者:: Sommerstein, R, 等
出版事項: (2015)

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
著者:: Rami Sommerstein, 等
出版事項: (2015-11-01)

Synthesis of N-glycan oxazolines: donors for endohexosaminidase catalysed glycosylation.
著者:: Rising, T, 等
出版事項: (2006)

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
著者:: Parham Jabbarzadeh Kaboli, 等
出版事項: (2025-02-01)

N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
著者:: Mihaela-Olivia Dobrica, 等
出版事項: (2020-06-01)

Glycosylation network mapping and site-specific glycan maturation in vivo
著者:: Marie-Estelle Losfeld, 等
出版事項: (2022-11-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
著者:: Julien J, 等
出版事項: (2012-09-01)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
著者:: Qing Wei, 等
出版事項: (2020-11-01)

Antibody evasion by a gammaherpesvirus O-glycan shield.
著者:: Bénédicte Machiels, 等
出版事項: (2011-11-01)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
著者:: Esteban Cruz, 等
出版事項: (2021-10-01)

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
著者:: Naveen Vankadari, 等
出版事項: (2020-01-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
著者:: Pejchal, R, 等
出版事項: (2011)

Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology
著者:: Jonathan J Lyons, 等
出版事項: (2015-06-01)

Multivalent interactions between fully glycosylated influenza virus hemagglutinins mediated by glycans at distinct N-glycosylation sites
著者:: Ruofan Li, 等
出版事項: (2024-10-01)

Fine structure of the HIV-1 glycan shield - Supplementary information
著者:: Behrens, A
出版事項: (2017)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
著者:: Tongqing Zhou, 等
出版事項: (2017-04-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
著者:: Muriel Lavie, 等
出版事項: (2018-04-01)

Structural constraints determine the glycosylation of HIV-1 envelope trimers
著者:: Pritchard, L, 等
出版事項: (2015)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
著者:: Rajesh P Ringe, 等
出版事項: (2023-10-01)

Controlled site-selective protein glycosylation for precise glycan structure-catalytic activity relationships.
著者:: Davis, B, 等
出版事項: (2000)